Cancer Immunotherapy
Join us at facebook
  • General information
  • For clinicians
    • How to apply
  • Research Group
  • For patients
  • Support us
  • Bladder Cancer - current trial
  • Different forms of cancer
    • Bladder Cancer
    • Gastrointestinal
    • Liver cancer
    • Lung metastases of Kidney cancer
    • Lung Metastases
    • Melanoma
    • Mesothelioma
    • Nasopharynx
    • Prostate Cancer
    • Other Cancers
  • FAQs
  • Contact
  • Veterinary immunotherapy
  • Nederlandse website
  • Dieren met kanker (NL)
  • Links

Nasopharyngeal carcinoma

Picture
Nasopharyngeal carcinoma is a malignant and difficult to access cancer of the nasopharynx. We have treated stage III and IV of nasopharyngeal carcinoma with irradiation and local IL-2 therapy. Five years disease-free survival after irradiation only was 8%, whereas after the combination irradiation local-IL-2 therapy, it was 63%.

References

Jacobs et al. (2005) Cancer Immunol. Immunother. 54, 792
Powered by Create your own unique website with customizable templates.